Aleafia Health Announces Update Regarding Agreement to Amend Convertible Debentures and Equity Financing
Retrieved on:
Thursday, June 2, 2022
Record, CFO, Company, BCE Inc v 1976 Debentureholders, Date, OTCQX, Income, CEO, LP2, Debenture, Extraordinary resolution, Conversion, GLOBE, Media relations, Solicitation, Support, TSX, Effective date, Grey Literature International Steering Committee, The Meeting, Debt, Indian stock exchange, Committee, SEDAR, Security (finance), Risk management
We are delighted that so many Debentureholders have already expressed support for the debenture amendments by delivering Support Agreements, said Tricia Symmes, CEO.
Key Points:
- We are delighted that so many Debentureholders have already expressed support for the debenture amendments by delivering Support Agreements, said Tricia Symmes, CEO.
- The Debenture Amendments, coupled with the $5.6 million in equity financing, are part of an ongoing transformation of our balance sheet.
- The Convertible Debentures which were to mature and be repaid by June 27, 2022, will be split into three series of equivalent size maturing in years 2024, 2026, and 2028.
- The equity financing in conjunction with our revolving receivables facility provides us liquidity to continue driving revenue growth, said Matt Sale, CFO.